메뉴 건너뛰기
American Journal of Roentgenology
Volumn 196, Issue 5, 2011, Pages 1225-1233
18F-FDG PET/CT of cervical carcinoma
Author keywords

Cervical carcinoma; FIGO; PET CT; Response assessment
Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;
EID: 79959603513     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.5084     Document Type: Review
Times cited : (38)
References (15)
  • 2
    • 64049094855 scopus 로고    scopus 로고
    • Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
    • Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009; 105:103-104
    • (2009) Int J Gynaecol Obstet , vol.105 , pp. 103-104
    • Pecorelli, S.1
  • 3
    • 0035449659 scopus 로고    scopus 로고
    • Lymph node staging by positron emission tomography in patients with carcinoma of the cervix
    • Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001; 19:3745-3749 (Pubitemid 32844787)
    • (2001) Journal of Clinical Oncology , vol.19 , Issue.17 , pp. 3745-3749
    • Grigsby, P.W.1    Siegel, B.A.2    Dehdashti, F.3
  • 5
    • 35048861568 scopus 로고    scopus 로고
    • The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival
    • DOI 10.1002/cncr.22974
    • Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer 2007; 110:1738-1744 (Pubitemid 47557298)
    • (2007) Cancer , vol.110 , Issue.8 , pp. 1738-1744
    • Kidd, E.A.1    Siegel, B.A.2    Dehdashti, F.3    Grigsby, P.W.4
  • 6
    • 77949390752 scopus 로고    scopus 로고
    • Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer
    • Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer. Cancer 2010; 116:1469-1475
    • (2010) Cancer , vol.116 , pp. 1469-1475
    • Kidd, E.A.1    Siegel, B.A.2    Dehdashti, F.3    Grigsby, P.W.4
  • 9
    • 32544441102 scopus 로고    scopus 로고
    • Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: A prospective study
    • DOI 10.1002/cncr.21641
    • Choi HJ, Roh JW, Seo SS, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer 2006; 106: 914-922 (Pubitemid 43238460)
    • (2006) Cancer , vol.106 , Issue.4 , pp. 914-922
    • Choi, H.J.1    Roh, J.W.2    Seo, S.-S.3    Lee, S.4    Kim, J.-Y.5    Kim, S.-K.6    Kang, K.W.7    Lee, J.S.8    Jeong, J.Y.9    Park, S.-Y.10
  • 10
    • 72249087133 scopus 로고    scopus 로고
    • Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging
    • Liu FY, Yen TC, Chen MY, et al. Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging. Cancer 2009; 115:5470-5480
    • (2009) Cancer , vol.115 , pp. 5470-5480
    • Liu, F.Y.1    Yen, T.C.2    Chen, M.Y.3
  • 11
    • 54049139554 scopus 로고    scopus 로고
    • Prospective clinical trial of positron emission tomography/computed tomography image-guided intensity-modulated radiation therapy for cervical carcinoma with positive paraaortic lymph nodes
    • Esthappan J, Chaudhari S, Santanam L, et al. Prospective clinical trial of positron emission tomography/computed tomography image-guided intensity-modulated radiation therapy for cervical carcinoma with positive paraaortic lymph nodes. Int J Radiat Oncol Biol Phys 2008; 72:1134-1139
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , pp. 1134-1139
    • Esthappan, J.1    Chaudhari, S.2    Santanam, L.3
  • 12
    • 2942642492 scopus 로고    scopus 로고
    • 18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: Response and outcome
    • 18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol 2004; 22:2167-2171
    • (2004) J Clin Oncol , vol.22 , pp. 2167-2171
    • Grigsby, P.W.1    Siegel, B.A.2    Dehdashti, F.3    Rader, J.4    Zoberi, I.5
  • 13
    • 36349035495 scopus 로고    scopus 로고
    • Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma
    • DOI 10.1001/jama.298.19.2289
    • Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA 2007; 298:2289-2295 (Pubitemid 350146219)
    • (2007) Journal of the American Medical Association , vol.298 , Issue.19 , pp. 2289-2295
    • Schwarz, J.K.1    Siegel, B.A.2    Dehdashti, F.3    Grigsby, P.W.4
  • 15

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.